Sale is live|00:00:00left today

Last analyzed: May 14, 2026 (Q1 FY26)

Gilead Sciences, Inc. Q1 FY26 US Stock Analysis

Gilead Sciences, Inc.

GILD

Healthcare

$133.05

Market Cap

—

P/E Ratio

—

Revenue Rank

Rank 4

Margin Rank

Rank 2

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Concall Period:

Q1 FY26

Explore More Tools

Discover more ways to research and analyze Indian stocks

Stock RankingsAI-ranked stocks from earnings calls Stock ScreenerFilter by P/E, ROE, growth & more IPO DashboardUpcoming, open & listed IPOs Compare StocksSide-by-side stock comparison CalculatorsSIP, CAGR, EMI & more Earnings CalendarUpcoming earnings calls Analyze PortfolioAI health check for your portfolio BlogMarket insights & guides